Early Release
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 9—September 2026
Synopsis
- Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway
Research
- Improved Case Detection of Flea-Borne Typhus through Polymerase Chain Reaction Testing, Los Angeles County, California, 2022–2024
Dispatches
- Chronic Elbow Nodules Caused by Fomitiporella Fungus in Immunocompetent Patients, United States
-
Serologic Evidence of Hantavirus Exposure in Humans, Italy, 2004–2018
Rodentborne hantaviruses and lymphocytic choriomeningitis virus (LCMV) circulate in northern Italy but are rarely diagnosed. We tested samples collected from 371 patients during 2004–2018 and detected LCMV IgG in 2.7% of samples and hantavirus IgG in 7.3%. Puumala virus–neutralizing antibodies were confirmed in 10 cases, indicating unrecognized local hantavirus circulation.
- Serologic Evidence of Hantavirus Exposure in Humans, Italy, 2004–2018
-
Seroprevalence of Influenza A(H5N1) Virus in Domestic Cats at Epicenter of Dairy Cattle Outbreaks, California, USA, 2024–2026
We conducted a serologic study of domestic cats near the epicenter of the dairy cattle outbreaks of influenza A(H5N1) in California, USA. Three of the 12 cats sampled within 2 km of farms had neutralizing antibodies against H5N1 virus. Proximity to dairy farms was a statistically significant risk factor for seropositivity.
- Genetically Distinct African Swine Fever Virus Genotype II Variant in Wild Boar, Spain, 2025–2026
-
Genomic and Epidemiologic Insights into Ongoing Measles Outbreak, Israel, 2025–2026
An ongoing measles outbreak in Israel, involving ≈3,200 cases and 16 deaths, threatens the country’s measles elimination status and reflects declining vaccination rates observed globally and within Israel. Epidemiologic investigations supported by sequencing suggest that a single importation triggered the outbreak, underscoring the critical role of rapid genomic surveillance in outbreak control.
Research Letters
- Locally-Acquired Pulmonary Coccidioidomycosis Linked to Maritime Shipping Containers, Taiwan, 2025
- Rickettsia massiliae infection in a peri-urban area, Spain, 2023
- Outbreak of Brazilian spotted fever, Southeastern Brazil, 2018
-
Southern Tick–Associated Rash Illness in Pediatric Patient, New York, USA, 2025
Southern tick–associated rash illness (STARI) is a tickborne disease of unknown etiology characterized by an erythema migrans–like skin lesion. We report a STARI case in New York in a child after an Amblyomma americanum tick bite; we detected Borrelia lonestari, a disputed cause of STARI, in the tick.
- Autochthonous Canine Pythiosis Linked with Freshwater Exposure, Italy, 2021–2024
- Powassan Virus in Ixodes scapularis Populations, Illinois, United States, 2025
- Pediatric Tuberculosis Care Outcomes in a Tertiary Care Center, France, 2014–2024
Letters
- Pulmonary Histoplasmosis, Taiwan, 1997–2024
- Pulmonary Histoplasmosis, Taiwan, 1997–2024
- Plausible Source Cases for Recent Mycobacterium tuberculosis Transmission, United States, 2018-2022
Volume 32, Number 10—October 2026
Research
- Wastewater Surveillance to Track a Resurgent Outbreak of Measles, Ontario, Canada, 2025
Dispatches
- Emergence of Divergent H5N1 (Clade 2.3.4.4b) in Central Park in São Paulo, Brazil, 2025
-
Emergence of Rabies in Cape Fur Seals, South Africa
Rabies was diagnosed in Cape fur seals by using direct fluorescent antibody testing in South Africa, 2024. We investigated the origin of rabies virus in this species. Phylogenetic analysis revealed virus introduction from jackals into seals, followed by sustained viral transmission within the seal population and spillover into a domestic dog.
- Emergence of Macrolide-Resistant Bordetella pertussis in Peru
Research Letter
- Highly pathogenic avian influenza virus subtype 5 in Brazilian cetaceans: implications for surveillance in threatened species Influenza A Virus in Cetaceans from Brazil
In Memoriam
Volume 32, Supplement –Summer 2026
- Implementation and Early Outcomes of Laboratory Proficiency Testing Program for National Wastewater Surveillance System, USA, 2024
- Evaluation of Detection Methods for Wastewater Surveillance of Antimicrobial-Resistant Bacteria from Healthcare Facilities
- Early-Season Detection of Influenza A(H3N2) Subclade K in Wastewater, Colorado, USA, 2025–26
- Mpox Surveillance in Wastewater, North Carolina, USA, October 2023–May 2025
-
Targeted Wastewater Surveillance during the World Athletics Championship, Oregon, USA, 2022
Targeted wastewater surveillance during the 18th World Athletics Championships in Eugene, Oregon, USA, in 2022 detected influenza A virus, SARS-CoV-2, and hepatitis A virus. Poliovirus detections were inconclusive. Influenza B, hepatitis E, and measles viruses and Middle East respiratory syndrome coronavirus were not detected. Wastewater surveillance augments traditional surveillance to mitigate risks associated with large multinational gatherings.
- Wastewater Respiratory Virus Surveillance in Remote Community, Alaska, 2022–2024
- Correlations between Wastewater Concentrations of Influenza A and Respiratory Syncytial Viruses and Clinical Laboratory Testing and Hospitalization Data, California
- Exploration of Public Perceptions of Wastewater Surveillance, United States, June 2024
- Temporal Alignment of Wastewater-based Signals with Clinical Indicators of Respiratory Illness in Post-Pandemic Texas
- Building National Wastewater Surveillance for Infectious Diseases in the United States
-
A Multi-Partner Effort to Launch and Sustain Wastewater Surveillance, United States
The National Wastewater Surveillance System represents a groundbreaking initiative aimed at enhancing public health surveillance for infectious diseases through wastewater analyses. We have outlined current and planned collaborative efforts between the Centers for Disease Control and Prevention and key partners, including academic institutions, utilities, jurisdictions, and public health partner networks, to develop, implement, and sustain wastewater surveillance for infectious diseases to inform public health activities. By addressing critical challenges in assay development, community and clinician engagement, governance structures, public health ethics, data system development and integration, and innovation fostering, those partnerships lay the groundwork for a robust public health surveillance framework. Establishing this novel public health surveillance capability required developing new partnerships and skills, incorporating basic principles of public health surveillance, validating assays, and envisioning a system to meet current and future public health challenges. This capability will foster improved public health responses nationwide.





